Back
Alnylam Pharmaceuticals Stock Price Chart
Sponsored
ALNY
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
ALNY
Alnylam Pharmaceuticals
Last Price:
244.97
Seasonality Move:
11.66%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
Alnylam Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 245.62 | Sell |
20-day SMA: | 263.27 | Sell |
50-day SMA: | 272.49 | Sell |
200-day SMA: | 211.63 | Buy |
8-day EMA: | 248.36 | Sell |
20-day EMA: | 259.36 | Sell |
50-day EMA: | 265.3 | Sell |
200-day EMA: | 231.03 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.65 | Sell |
Relative Strength Index (14 RSI): | 37.82 | Sell |
Chaikin Money Flow: | -229766 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (250.02 - 288.16) | Sell |
Bollinger Bands (100): | (248.72 - 281.72) | Sell |
Alnylam Pharmaceuticals Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 244.89 while ALNY 8-day simple moving average is 245.62, which is a Sell signal.
- The stock price of ALNY is 244.89 while Alnylam Pharmaceuticals 20-day SMA is 263.27, which makes it a Sell.
- Alnylam Pharmaceuticals 50-day simple moving average is 272.49 while ALNY share price is 244.89, making it a Sell technically.
- ALNY stock price is 244.89 and Alnylam Pharmaceuticals 200-day simple moving average is 211.63, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $244.89. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
31.59B
Price in USD:
244.89
Share Volume:
516.28K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 244.89 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 244.89 while ALNY 8-day exponential moving average is 248.36, which is a Sell signal.
- The stock price of ALNY is 244.89 while Alnylam Pharmaceuticals 20-day EMA is 259.36, which makes it a Sell.
- Alnylam Pharmaceuticals 50-day exponential moving average is 265.30 while ALNY share price is 244.89, making it a Sell technically.
- ALNY stock price is 244.89 and Alnylam Pharmaceuticals 200-day simple moving average is 231.03, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is -9.65, suggesting Alnylam Pharmaceuticals is a Sell
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 37.82, which suggest Alnylam Pharmaceuticals is oversold
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (250.02 - 288.16), which suggest Alnylam Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (248.72 - 281.72), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.